Prophylactic Donor Lymphocyte Infusions in Pediatric Patients With High‐Risk Hematological Malignancies

Documenti analoghi

• Efficacy and Safety of Donor Lymphocyte Infusion After Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients
  di: Dinah Walther, et al.
  Pubblicazione: (2026)
• Allogeneic Haematopoietic Stem Cell Transplantation Using Reduced‐Intensity Fludarabine, Busulfan and Anti‐T‐Lymphocyte Globulin With Strategic Donor Lymphocyte Infusion in Older Patients With Myeloid Malignancy
  di: Chris Armstrong, et al.
  Pubblicazione: (2025)
• The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives
  di: Waseem Alzamzami
  Pubblicazione: (2025)
• Emerging Techniques in Minimally Invasive Surgery in Hematologic Malignancies
  di: Alejandro Chara, et al.
  Pubblicazione: (2025)
• Postoperative Care and Management in Pediatric Hematology‐Oncology Patients
  di: Shachi Srivatsa, et al.
  Pubblicazione: (2026)